Remove 2025 Remove Medicare Remove Outcomes
article thumbnail

Medtronic Presents New Data, Clinical Milestones at CRT 2025

DAIC

tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.

article thumbnail

SCAI Scientific Sessions 2025 to Feature Presentations on TAVR, PAD and PE 

DAIC

tim.hodson Fri, 03/14/2025 - 16:12 SCAI Scientific Sessions 2025 will take place May 1 to 3, attheWalter E. Washington Convention Center in Washington, DC.

TAVR 52
article thumbnail

New Tool Helps Predict Stroke Outcome with Higher Accuracy

DAIC

tim.hodson Thu, 01/30/2025 - 15:31 Jan. 29, 2025 Researchers atOchsner Health, led byHernan Bazan, MD, DFSVS, FACS, have developed a predictive model with a 93% accuracy rate in determining whether urgent carotid-intervention patients will regain functional independence. For information please visit Reference: Bazan HA et al.

Stroke 52
article thumbnail

Surgeon Preference Impacts Survival Outcomes Analyses for CABG Patients

DAIC

tim.hodson Fri, 01/24/2025 - 11:51 Jan. 24, 2025 In-patients undergoing coronary artery bypass grafting (CABG), a novel analysis evaluating surgeon preference for multi- versus single-arterial grafting may help explain the differing results between prior retrospective analyses and randomized controlled trials regarding long-term survival.

article thumbnail

Revolution Vibe CT System Now Available from GE Healthcare

DAIC

tim.hodson Fri, 03/28/2025 - 15:23 Mar. vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible. a huge win: CMS significantly increases Medicare payments for cardiac CT. For more information on Revolution Vibe, please visit gehealthcare.com.

article thumbnail

Abstract 63: Medicare Advantage Appears to Promote Stroke Prevention and Functional Independence Measure Gains with Lower Utilization than Fee-for-Service Medicare

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page A63-A63, February 1, 2025. Introduction:Stroke prevalence is highest in adults ages>65 years, the majority of whom are Medicare beneficiaries. Fee-for-Service (FFS) Medicare incentivizes utilization by paying for each service. Improvements in functional outcomes were greater.

article thumbnail

GE Healthcare Launches New Cardiac PET tracer

DAIC

tim.hodson Thu, 03/27/2025 - 15:40 March 27, 2025 GE HealthCare is announcing theU.S.launch of Flyrcado(flurpiridaz F 18) injection at the 2025American College of Cardiology(ACC) AnnualScientific Session & Expo inChicago. Flyrcado is aunit dose positron emission tomography myocardial perfusion imaging (PET MPI) agent.